Behavioral Weight Loss Treatment for Obesity
(REBOOT Trial)
Trial Summary
What is the purpose of this trial?
This trial aims to understand why people with lower income have more difficulty losing weight. Participants will follow a typical weight loss program, and researchers will study how focusing on immediate needs and daily stress affect their success. The goal is to find better ways to help these individuals stick to their weight loss plans.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are currently engaged in another weight loss therapy, you cannot participate.
What data supports the effectiveness of the treatment for obesity?
Is behavioral weight loss treatment safe for humans?
How is behavioral weight loss treatment different from other obesity treatments?
Behavioral weight loss treatment is unique because it focuses on changing eating, activity, and thinking habits through techniques like self-monitoring and cognitive restructuring, rather than relying solely on medication or surgery. It emphasizes long-term lifestyle changes and can be combined with other methods for better results.26101112
Research Team
Eligibility Criteria
This trial is for adults over 18 with obesity (BMI ≥30 kg/m2) who fall into specific socioeconomic status (SES) groups. Participants must live within 20 miles of Rush and have phone access. Those with a BMI over 60, severe medical conditions, cognitive impairments, substance abuse issues, or not fluent in English cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 6 months of group-based behavioral weight loss treatment following the CDC Prevent T2 curriculum
Follow-up
Participants are monitored for weight change and adherence to weight control behaviors
Treatment Details
Interventions
- Behavioral weight loss treatment (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Dr. Omar B. Lateef
Rush University Medical Center
Chief Executive Officer since 2022
MD from Des Moines University, Fellowship in Pulmonary and Critical Care Medicine at Rush University Medical Center
Dr. Paul E. Casey
Rush University Medical Center
Chief Medical Officer since 2021
MD, MBA